The US relies on existing federal laws and guidelines to regulate AI but aims to introduce AI legislation and a federal regulation authority. Until then, developers and deployers of AI systems will operate in an increasing patchwork of state and local laws, underscoring challenges to ensure compliance.
One of the most common ways AI is used in law is during the electronic discovery (e-Discovery) process. During e-Discovery, lawyers identify and organize electronically stored information (ESI) in response to a request for production in a lawsuit or investigation.
The question of AI rights remains largely hypothetical, contingent on future advancements in AI capabilities, particularly concerning autonomy and consciousness. While parallels can be drawn from the animal rights movement, AI's distinct nature as a human-created, non-sentient entity presents unique challenges.
September 11, 2024. (Washington, D.C.) – Today, the House Committee on Science, Space, and Technology passed nine bipartisan bills to ensure U.S. leadership in artificial intelligence (AI).
In February 2024, the UK Government's response to the AI White Paper consultation outlined a pro-innovation regulatory approach based on cross-sectoral principles, a context-specific framework, international collaboration, and voluntary measures for developers (here).
No, AI will not make lawyers obsolete. Instead, it will transform the profession, emphasizing the skills and qualities that are uniquely human.
“AI can help analyze and execute final contracts, but it won't do the full job,” said Lavan. “The technology is not at a point where it can handle these tasks unassisted. You still ultimately need a legal professional to review the final contract and ensure it's absolutely correct.”
As noted above, there is currently no comprehensive legislation in the US that directly regulates AI. However, the White House Executive Order on AI and proposed legislation at the federal and state level generally seeks to address the following issues: Safety and security. Responsible innovation and development.
Observations The FDA has authorized almost 1000 AI-enabled medical devices and has received hundreds of regulatory submissions for drugs that used AI in their discovery and development. Health AI regulation needs to be coordinated across all regulated industries, the US government, and with international organizations.
Ethical Concerns: The impersonal nature of AI raises questions about client confidentiality, privacy, and the erosion of the lawyer-client relationship. Hence, AI is highly unlikely to replace human lawyers. Dependence on Technology: Overreliance on AI tools may lead to skill atrophy among legal professionals.